E2F1 has been shown to directly upregulate the expression of the enzyme ISYNA1, the rate‐limiting step in the synthesis of mI via glucose‐6‐phosphate; inhibition of E2F1 may reduce the synthesis of mI and impair GBM progression.46 The gene discussed is E2F1; the disease is glioblastoma.